Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis

• Jan Philipp Bewersdorf,
• Smith Giri,
• Rong Wang,
• Robert T. Williams,
• Martin S. Tallman,
• Amer M. Zeidan,
• Maximilian Stahl

Affiliations

Jan Philipp Bewersdorf

Yale University;

Smith Giri

Division of Hematology and Oncology, University of Alabama School of Medicine;

Rong Wang

Department of Chronic Disease Epidemiology, School of Public Health, Yale University;

Robert T. Williams

Rockefeller University;

Martin S. Tallman

Memorial Hospital;

Amer M. Zeidan

Yale University;

Maximilian Stahl

Memorial Sloan Kettering Cancer Center